Press release
Investigation announced for Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) over possible Wrongdoing
An investigation on behalf of current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: MGX stocks follows a lawsuit filed against Metagenomi, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: MGX stocks, concerns whether certain Metagenomi, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that, the Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. The action seeks to compensate the Class members and recover the damages they sustained because of Defendants' allegedly false and misleading statements.
Those who purchased shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) over possible Wrongdoing here
News-ID: 3928112 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit Alert: Investors with Losses from purchases of Aldeyra Therapeutics, Inc …
An investor, who purchased shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), filed a lawsuit over alleged violations of Federal Securities Laws by Aldeyra Therapeutics, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) have certain options and for certain investors are short and strict deadlines running. Deadline: May 29, 2026. NASDAQ: ALDX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Ostin Technology Group Co., Ltd. (NASDAQ: OST) Investor Alert: Deadline in Lawsu …
A deadline is coming up on April 17, 2026 in the lawsuit filed for certain investors of Ostin Technology Group Co., Ltd. (NASDAQ: OST) over alleged securities laws violations by Ostin Technology Group Co., Ltd.
Investors who purchased shares of Ostin Technology Group Co., Ltd. (NASDAQ: OST) have certain options and there are strict and short deadlines running. Deadline: April 17, 2026. Ostin Technology Group Co., Ltd. (NASDAQ: OST) stockholders…
Telix Pharmaceuticals Limited (NASDAQ: TLX) Long Term Investor Alert: Investigat …
An investigation on behalf of current long-term investors in shares of Telix Pharmaceuticals Limited (NASDAQ: TLX) concerning potential breaches of fiduciary duties by certain directors and officers of Telix Pharmaceuticals Limited was announced.
Investors who are current long term investors in Telix Pharmaceuticals Limited (NASDAQ: TLX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for…
Lawsuit filed for Investors with Losses from purchases of Navan, Inc. (NASDAQ: N …
An investor, who purchased shares of Navan, Inc. (NASDAQ: NAVN), filed a lawsuit over alleged violations of Federal Securities Laws by Navan, Inc. (NASDAQ: NAVN in connection with certain allegedly false and misleading statements made in connection with Navan's October 31, 2025 initial public offering.
Investors who purchased shares of Navan, Inc. (NASDAQ: NAVN) have certain options and for certain investors are short and strict deadlines running. Deadline: April 24, 2026.…
More Releases for Metagenomi
Future Prospects: Key Trends Shaping the Base-Editing Tools Market Until 2030
The base-editing tools market is poised for remarkable expansion in the coming years as advancements in gene-editing technology gain momentum. This market's growth is driven by increasing applications in precision medicine, agriculture, and biotechnology, alongside innovations that are transforming how genetic modifications are performed and analyzed. Let's delve deeper into the current market landscape, key players, growth drivers, trends, and segmentation details shaping this exciting field.
Forecasted Expansion of the Base-Editing…
Cell Engineering Service Market Set to Grow Steadily Through 2025, Key Trends, R …
QY Research has recently published a research report titled, "Global Cell Engineering Service Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", assessing various factors impacting its trajectory. The research study offers deep evaluation of the global Cell Engineering Service market and helps market participants to gain a strong foothold in the industry. It sheds light on critical market dynamics such as drivers, restraints, trends, and opportunities to help…
2025-2034 Base-Editing Tools Market Evolution: Disruptions, Innovations, and Unt …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Base-Editing Tools Market Through 2025?
In recent times, the market size for base-editing tools has seen a staggering growth. Expected to expand from $1.50 billion in 2024 to $1.83 billion in 2025, it's forecasted to boast a compound annual growth rate (CAGR)…
Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) should contact t …
An investigation on behalf of current long-term investors in shares of Metagenomi, Inc. (NASDAQ: MGX) concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc. was announced.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of Metagenomi, Inc. (NASD …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 25, 2024. NASDAQ: MGX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit filed for Investors who lost money with Metagenomi, Inc. (NASDAQ: MGX) i …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements made between February 9 and 13, 2024.
Investors who purchased a significant amount of shares of Metagenomi, Inc. (NASDAQ: MGX) between February 9 and 13, 2024, have certain options and for certain investors are short and strict deadlines running.…
